Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDC Stresses Early Pneumococcal Vaccinations In New Flu Recommendations

Executive Summary

The Centers for Disease Control & Prevention is emphasizing the importance of administering pneumococcal vaccine to high-risk patients early in the season in light of delayed availability of influenza vaccine for the 2000-2001 flu season.

You may also be interested in...



FDA Vaccines Office Head Midthun Joins From Analgesic Division

FDA Office of Vaccines Research & Review Director Karen Midthun, MD, has experience in early development studies of vaccine candidates for HIV, hepatitis A and rotavirus.

FDA Vaccines Office Head Midthun Joins From Analgesic Division

FDA Office of Vaccines Research & Review Director Karen Midthun, MD, has experience in early development studies of vaccine candidates for HIV, hepatitis A and rotavirus.

King Fluogen Discontinued; Flu Vaccine Would Have Been Unavailable In 2000

King Pharmaceuticals will discontinue Fluogen following receipt of a Sept. 27 FDA letter concerning the flu vaccine.

UsernamePublicRestriction

Register

ID1132115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel